Yan Zheng1, Uta Ceglarek2, Tao Huang1, Lerong Li3, Jennifer Rood4, Donna H Ryan4, George A Bray4, Frank M Sacks1, Dan Schwarzfuchs5, Joachim Thiery2, Iris Shai6, Lu Qi7. 1. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA; 2. Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany; 3. Human Genetics Center, University of Texas Health Science Center School of Public Health, Houston, TX; 4. Pennington Biomedical Research Center of the Louisiana State University System, Baton Rouge, LA; 5. Nuclear Research Center Negev, Dimona, Israel; 6. Department of Public Health, Ben-Gurion University of the Negev, Beer-Sheva, Israel; and. 7. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA; Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA lqi1@tulane.edu.
Abstract
BACKGROUND: Circulating amino acids, such as branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs), have been associated with diabetes risk; however, little is known about how a long-term dietary intervention for weight loss affects circulating amino acids. OBJECTIVES: We examined the effects of weight-loss diets on long-term changes in plasma amino acids and the associations of these changes with weight loss and the improvement of insulin resistance. DESIGN: We repeatedly measured plasma amino acid profiles over 2 y in overweight or obese participants from 2 randomized, dietary intervention, weight-loss trials [774 subjects from the POUNDS LOST (Preventing Overweight Using Novel Dietary Strategies Trial) and 318 subjects from the DIRECT (Dietary Intervention Randomized Controlled Trial)]. RESULTS: Intervention diets consistently lowered most of the amino acid concentrations, including BCAAs and AAAs, in both trials. In the POUNDS LOST, average-protein diets (15% of daily energy) showed stronger effects than did high-protein diets (25% of daily energy) on reducing concentrations of the diabetes-associated BCAA valine at 6 mo independent of the weight change. In both trials, weight loss was directly related to the concurrent reduction of the BCAAs leucine and isoleucine, the AAAs tyrosine and phenylalanine, and 4 other amino acids. For example, per kilogram of weight loss, there was a 0.04-SD decrease in log tyrosine (∼0.6 μmol/L) in both trials. In addition, we showed that reductions in alanine and the AAA tyrosine were significantly related to improved insulin resistance (measured with the use of the homeostasis model assessment of insulin resistance), independent of weight loss, in both trials (both P < 0.05). For example, per 1-SD decrease in log tyrosine (∼17 μmol/L), there was a 0.04-SD (∼3%) improvement in insulin resistance in the POUNDS LOST and a 0.13-SD (∼8%) improvement in insulin resistance in the DIRECT. CONCLUSION: Our findings underscore the potential importance of dietary interventions in improving amino acid profiles (i.e., reducing diabetes risk-enhancing amino acid concentrations) along with and beyond weight loss. The POUNDS LOST and the DIRECT were registered at clinicaltrials.gov as NCT00072995 and NCT00160108, respectively.
RCT Entities:
BACKGROUND: Circulating amino acids, such as branched-chain amino acids (BCAAs) and aromatic amino acids (AAAs), have been associated with diabetes risk; however, little is known about how a long-term dietary intervention for weight loss affects circulating amino acids. OBJECTIVES: We examined the effects of weight-loss diets on long-term changes in plasma amino acids and the associations of these changes with weight loss and the improvement of insulin resistance. DESIGN: We repeatedly measured plasma amino acid profiles over 2 y in overweight or obeseparticipants from 2 randomized, dietary intervention, weight-loss trials [774 subjects from the POUNDS LOST (Preventing Overweight Using Novel Dietary Strategies Trial) and 318 subjects from the DIRECT (Dietary Intervention Randomized Controlled Trial)]. RESULTS: Intervention diets consistently lowered most of the amino acid concentrations, including BCAAs and AAAs, in both trials. In the POUNDS LOST, average-protein diets (15% of daily energy) showed stronger effects than did high-protein diets (25% of daily energy) on reducing concentrations of the diabetes-associated BCAA valine at 6 mo independent of the weight change. In both trials, weight loss was directly related to the concurrent reduction of the BCAAs leucine and isoleucine, the AAAstyrosine and phenylalanine, and 4 other amino acids. For example, per kilogram of weight loss, there was a 0.04-SD decrease in log tyrosine (∼0.6 μmol/L) in both trials. In addition, we showed that reductions in alanine and the AAA tyrosine were significantly related to improved insulin resistance (measured with the use of the homeostasis model assessment of insulin resistance), independent of weight loss, in both trials (both P < 0.05). For example, per 1-SD decrease in log tyrosine (∼17 μmol/L), there was a 0.04-SD (∼3%) improvement in insulin resistance in the POUNDS LOST and a 0.13-SD (∼8%) improvement in insulin resistance in the DIRECT. CONCLUSION: Our findings underscore the potential importance of dietary interventions in improving amino acid profiles (i.e., reducing diabetes risk-enhancing amino acid concentrations) along with and beyond weight loss. The POUNDS LOST and the DIRECT were registered at clinicaltrials.gov as NCT00072995 and NCT00160108, respectively.
Authors: Louise M Burke; Julie A Winter; David Cameron-Smith; Marc Enslen; Michelle Farnfield; Jacques Decombaz Journal: Int J Sport Nutr Exerc Metab Date: 2012-07-04 Impact factor: 4.599
Authors: Susan Cheng; Eugene P Rhee; Martin G Larson; Gregory D Lewis; Elizabeth L McCabe; Dongxiao Shen; Melinda J Palma; Lee D Roberts; Andre Dejam; Amanda L Souza; Amy A Deik; Martin Magnusson; Caroline S Fox; Christopher J O'Donnell; Ramachandran S Vasan; Olle Melander; Clary B Clish; Robert E Gerszten; Thomas J Wang Journal: Circulation Date: 2012-04-11 Impact factor: 29.690
Authors: Blandine Laferrère; David Reilly; Sara Arias; Nicholas Swerdlow; Prakash Gorroochurn; Baani Bawa; Mousumi Bose; Julio Teixeira; Robert D Stevens; Brett R Wenner; James R Bain; Michael J Muehlbauer; Andrea Haqq; Lillian Lien; Svati H Shah; Laura P Svetkey; Christopher B Newgard Journal: Sci Transl Med Date: 2011-04-27 Impact factor: 17.956
Authors: Martin Magnusson; Gregory D Lewis; Ulrika Ericson; Marju Orho-Melander; Bo Hedblad; Gunnar Engström; Gerd Ostling; Clary Clish; Thomas J Wang; Robert E Gerszten; Olle Melander Journal: Eur Heart J Date: 2012-12-13 Impact factor: 29.983
Authors: Yan Zheng; Bing Yu; Danny Alexander; Thomas H Mosley; Gerardo Heiss; Jennifer A Nettleton; Eric Boerwinkle Journal: Hypertension Date: 2013-06-17 Impact factor: 10.190
Authors: Yan Zheng; Bing Yu; Danny Alexander; Teri A Manolio; David Aguilar; Josef Coresh; Gerardo Heiss; Eric Boerwinkle; Jennifer A Nettleton Journal: Am J Epidemiol Date: 2013-06-20 Impact factor: 4.897
Authors: Annabel A Ferguson; Sudipa Roy; Kaitlyn N Kormanik; Yongsoon Kim; Kathleen J Dumas; Vladimir B Ritov; Dietrich Matern; Patrick J Hu; Alfred L Fisher Journal: PLoS Genet Date: 2013-12-19 Impact factor: 5.917
Authors: Miguel Ruiz-Canela; Marta Guasch-Ferré; Estefanía Toledo; Clary B Clish; Cristina Razquin; Liming Liang; Dong D Wang; Dolores Corella; Ramón Estruch; Álvaro Hernáez; Edward Yu; Enrique Gómez-Gracia; Yan Zheng; Fernando Arós; Dora Romaguera; Courtney Dennis; Emilio Ros; José Lapetra; Lluis Serra-Majem; Christopher Papandreou; Olga Portoles; Montserrat Fitó; Jordi Salas-Salvadó; Frank B Hu; Miguel A Martínez-González Journal: Diabetologia Date: 2018-04-16 Impact factor: 10.122
Authors: Yoriko Heianza; Dianjianyi Sun; Xiang Li; Joseph A DiDonato; George A Bray; Frank M Sacks; Lu Qi Journal: Gut Date: 2018-06-02 Impact factor: 23.059
Authors: Deyang Yu; Nicole E Richardson; Cara L Green; Alexandra B Spicer; Michaela E Murphy; Victoria Flores; Cholsoon Jang; Ildiko Kasza; Maria Nikodemova; Matthew H Wakai; Jay L Tomasiewicz; Shany E Yang; Blake R Miller; Heidi H Pak; Jacqueline A Brinkman; Jennifer M Rojas; William J Quinn; Eunhae P Cheng; Elizabeth N Konon; Lexington R Haider; Megan Finke; Michelle Sonsalla; Caroline M Alexander; Joshua D Rabinowitz; Joseph A Baur; Kristen C Malecki; Dudley W Lamming Journal: Cell Metab Date: 2021-04-21 Impact factor: 27.287